Urolithin B: A Novel Metabolite Combating IAPP Proteotoxicity for Diabetes Management
Discover how Urolithin B targets Islet Amyloid Polypeptide to offer new hope in managing Type 2 Diabetes.
Get a Quote & SampleProduct Core Value
Urolithin B Powder
Urolithin B is a key metabolite derived from ellagic acid, offering significant therapeutic potential in combating Islet Amyloid Polypeptide (IAPP) proteotoxicity, a critical factor in Type 2 Diabetes progression. Research highlights its ability to interfere with the early stages of IAPP aggregation, leading to the formation of less toxic species and promoting improved cellular health.
- Investigate the role of Urolithin B in combating IAPP proteotoxicity, a significant factor contributing to the cellular dysfunction observed in Type 2 Diabetes.
- Explore how this potent metabolite interferes with the early stages of IAPP aggregation inhibitor, reshaping low-order oligomeric species for improved cellular outcomes.
- Understand the Urolithin B cellular protection mechanisms, including enhanced autophagy and maintenance of mitochondrial function, crucial for overall cell viability.
- Learn about the natural compound for diabetes that offers a dual approach by stabilizing protein structure and bolstering cellular defense systems.
Key Advantages of Urolithin B
Reduced IAPP Aggregation
Urolithin B significantly prolongs the lag phase in IAPP aggregation and alters the size and morphology of amyloid fibrils, a crucial step in mitigating IAPP toxicity.
Enhanced Cellular Clearance
The compound facilitates faster clearance of IAPP from cells, working in conjunction with cellular mechanisms like autophagy to reduce protein burden.
Mitochondrial Support & Antioxidant Action
Urolithin B helps maintain mitochondrial membrane potential and reduces reactive oxygen species (ROS) levels, counteracting oxidative stress associated with IAPP damage.
Key Applications
Healthcare Supplement Formulation
Integrate Urolithin B into dietary supplements aimed at supporting metabolic health and addressing cellular dysfunction linked to diabetes.
Nutraceutical Development
Leverage Urolithin B's properties for developing advanced nutraceuticals targeting chronic conditions and promoting longevity.
Pharmaceutical Research
Explore Urolithin B as a lead compound for novel pharmaceutical interventions against protein misfolding diseases, including diabetes.
Targeting Metabolic Disorders
Utilize Urolithin B's multifaceted benefits for metabolic disorders, offering a solution for consumers seeking natural health support.